On Jan 11, 2022 Freenome closed a Corporate Round round and raised $290,000,000 from Roche, featuring lead investors Roche. About the company: Freenome is located […]
Series A – PostEra
On Jan 11, 2022 PostEra closed a Series A round and raised $24,000,000 from ACE & Company, Breyer Capital, Clermont Group, HOF Capital, I2BF Global […]
Corporate Round – Freenome
On Jan 11, 2022 Freenome closed a Corporate Round round and raised $290,000,000 from Roche, featuring lead investors Roche. About the company: Freenome is located […]
Callahan Chemical Company acquired by Tilley-Phoenix Group
Jan 5, 2022 Tilley-Phoenix Group has entered into an agreement to acquire Callahan Chemical Company . Tilley-Phoenix Group based at Baltimore, Maryland, United States. ” […]
Series A – AvengeBio
On Jan 5, 2022 AvengeBio closed a Series A round and raised $45,000,000 from CAM Capital, Longitude Capital, Pappas Capital, Perceptive Advisors, Rock Springs Capital, […]
Pre Seed Round – BioShumm
On Jan 5, 2022 BioShumm closed a Pre-Seed round and raised $15,000 from HMG Invest, featuring lead investors HMG Invest. About the company: BioShumm is […]
Series C – Life Biosciences
On Jan 5, 2022 Life Biosciences closed a Series C round and raised $82,000,000 from Alpha Wave Ventures, George Godula, featuring lead investors Alpha Wave […]
Post-IPO Debt – Innate Pharma
On Jan 5, 2022 Innate Pharma closed a Post-IPO Debt round and raised €28,700,000 from BNP Paribas, Societe Generale, featuring lead investors . About the […]
Seed Round – Protai
On Jan 5, 2022 Protai closed a Seed round and raised $8,000,000 from Grove Ventures, Pitango Venture Capital, featuring lead investors Grove Ventures, Pitango Venture […]
Series B – Korro Bio
On Jan 5, 2022 Korro Bio closed a Series B round and raised $116,000,000 from Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Eventide Asset […]
